Delivery Order SPE2DB20D1100-SPE2DB25FE4F7
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,160.10 by the Defense Logistics Agency on August 12, 2025, for the supply of Dexcom G7 sensors. The contract represents a firm fixed price, non-set-aside award with an ultimate completion date of August 13, 2025, and will be fulfilled at the vendor's Conshohocken facility. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,047.62 by the Defense Logistics Agency on July 23, 2025, for the supply of Dexcom G7 sensors. The award, which carries an ultimate completion date of July 24, 2025, was competitively awarded with firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $2,892.38 for the supply of Dexcom G7 sensors. The contract, awarded on September 3, 2025, with an ultimate completion date of September 4, 2025, carries a firm fixed price structure and represents a competitively awarded, non-set-aside transaction. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,172.52 by the Defense Logistics Agency on September 25, 2025, for the supply of Dexcom G7 sensors. This firm fixed-price delivery order, with an ultimate completion date of September 26, 2025, was competitively awarded without a set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $1,023.62 firm fixed-price delivery order for Dexcom G7 sensors, with an ultimate completion date of September 5, 2025. This competitively awarded contract, issued on September 4, 2025, represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,361.44 to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of August 6, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,031.20 by the Defense Logistics Agency on September 25, 2025, for the supply of Dexcom G7 sensors. This is a firm fixed price delivery order with no set-aside designation, executed competitively under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The performance...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) for Dexcom G7 sensors, a continuous glucose monitoring device used in diabetes management. The contract was awarded on September 9, 2025, with a ceiling value of $4,398.40 and a firm fixed-price structure. The ultimate completion date is September 10, 2025. This is a non-set-aside, competitively awarded delivery order performed at AmerisourceBergen's Conshohocken, Pennsylvania location. This...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $19,621.02 by the Defense Logistics Agency (DLA) on June 20, 2025, for the supply of Dexcom G7 sensors, with an ultimate completion date of June 23, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,749.25 to supply Dexcom G7 sensors, with an ultimate completion date of July 29, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE4F7Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $1,822.66 for Dexcom G7 sensors by the Defense Logistics Agency (DLA). The award, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a firm fixed price contract with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical devices to support military healthcare programs globally. The Dexcom G7 continuous glucose monitoring sensors are medical devices used for diabetes management and represent part of AmerisourceBergen's extensive portfolio of specialized healthcare commodities supplied to federal military and veteran healthcare systems. As a competitively awarded contract without set-aside provisions, this delivery order demonstrates the company's capability to meet federal procurement requirements while serving critical medical supply needs of the Defense Health Agency and other government healthcare systems through its flexible prime vendor contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 9/3/25 |